Baird Medical Investment Holdings (BDMD) Current Deferred Revenue (2023 - 2025)

Baird Medical Investment Holdings' Current Deferred Revenue history runs 3 years deep, the most recent figure standing at $793412.0 for Q4 2025.

• In Q4 2025, Current Deferred Revenue changed 0.17% year-over-year to $793412.0; the TTM figure through Dec 2025 stood at $793412.0 (changed 0.17% YoY), while the FY2025 annual figure was $793412.0, changed 0.17% from the prior year.
• Current Deferred Revenue was $793412.0 for Q4 2025 at Baird Medical Investment Holdings, down from $1.1 million in the prior quarter.
• In the past five years, Current Deferred Revenue ranged from a high of $1.1 million in Q2 2025 to a low of $200000.0 in Q4 2023.
• Historically, Current Deferred Revenue has averaged $719737.0 across 3 years, with a median of $792757.0 in 2024.
• The sharpest annual moves came in 2024 and 2025: Current Deferred Revenue soared 296.05% in 2024, then advanced 0.17% in 2025.
• A 3-year view of Current Deferred Revenue shows it stood at $200000.0 in 2023, then jumped by 296.05% to $792102.0 in 2024, then gained by 0.17% to $793412.0 in 2025.
• The last three Current Deferred Revenue figures came in at $793412.0 (Q4 2025), $1.1 million (Q2 2025), and $792102.0 (Q4 2024), per Business Quant data.